(0.10%) 5 522.50 points
(0.12%) 39 893 points
(0.23%) 19 796 points
(-0.01%) $81.62
(0.53%) $2.83
(-0.30%) $2 337.40
(0.07%) $29.55
(0.28%) $1 004.60
(-0.01%) $0.931
(-0.05%) $10.53
(-0.02%) $0.788
(-0.85%) $87.25
7.78% $ 0.194
Live Chart Being Loaded With Signals
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning...
Stats | |
---|---|
Dzisiejszy wolumen | 19 116 |
Średni wolumen | 17 863 |
Kapitalizacja rynkowa | 1.23M |
EPS | $-1.760 ( Q4 | 2023-03-31 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.0721 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00900 (4.64%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-11-09 | Hansen Paul R. | Buy | 6 783 | Common Stock, $0.0001 par value |
2023-01-17 | Hansen Paul R. | Buy | 4 032 | Common Stock, $0.0001 par value |
2023-01-17 | Harris Geoffrey E. | Buy | 5 712 | Common Stock, $0.0001 par value |
2023-01-17 | Fletcher R John | Buy | 4 368 | Common Stock, $0.0001 par value |
2023-01-17 | Horobin Joanna | Buy | 7 526 | Common Stock, $0.0001 par value |
INSIDER POWER |
---|
97.94 |
Last 98 transactions |
Buy: 5 441 265 | Sell: 193 337 |
Wolumen Korelacja
Cancer Genetics Inc Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cancer Genetics Inc Korelacja - Waluta/Towar
Cancer Genetics Inc Finanse
Annual | 2022 |
Przychody: | $666 000 |
Zysk brutto: | $-342 000 (-51.35 %) |
EPS: | $-3.87 |
FY | 2022 |
Przychody: | $666 000 |
Zysk brutto: | $-342 000 (-51.35 %) |
EPS: | $-3.87 |
FY | 2021 |
Przychody: | $1.15M |
Zysk brutto: | $-699 000 (-60.89 %) |
EPS: | $-9.03 |
FY | 2020 |
Przychody: | $867 000 |
Zysk brutto: | $-234 000 (-26.99 %) |
EPS: | $-1.492 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cancer Genetics Inc
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). Vyant Bio, Inc. has a collaboration agreement to discover drugs for the treatment of Parkinson's Disease. The company is based in Cherry Hill, New Jersey.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej